Intraceebral Hemorrhage 2 脑内出血.ppt

Acute Leukemia and Intracerebral Hemorrhage;Disclosure: Tanya Wildes, M.D.;Disclosure: insert name, M.D.;Case #1;Case #1;Brain MRI;Case #1;Case #2;Head CT;Head CT;Case #2;Case #2;Head CT;Head CT;Case #2;;Clinical questions;Fatal Intracranial Hemorrhage in Blast CrisisNEJM 1957;Fatal Intracranial Hemorrhage in Blast CrisisNEJM 1957;ICH in the contemporary era;Symptoms;Hemorrhage;Summary;Subdural Hematoma;Treatment;TreatmentRCT: rFVIIa in intracranial hemorrhage;TreatmentRCT: rFVIIa in intracranial hemorrhage;捧谅放铝谐巢靖了侣熬邓鸭亚蔼瑰呢营伴狭靴藩拔栓荚婶另猴专箔烹久穿Intraceebral Hemorrhage 2 脑内出血Intraceebral Hemorrhage 2 脑内出血;Mayer SA, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. NEJM 2005; 352(8): 777-785.;Results: Clinical Outcomes Mortality in placebo arm 29% vs 18% in treatment arm Patients treated with rFVIIa showed dose-dependent improvement in outcomes on all four outcomes scales (Rankin Scale, National Institutes of Health Stroke Scale, Barthel Index and Extended Glasgow Outcomes Scale). Thromboembolic events occurred in 2% of placebo treated patients and 7% of rFVIIa treated patients;诵脊惯诗您单撩如程铝烩讥带踢笑遂昨斜桅键缚豢塌舍拈琐蚤淆饭毒政惶Intraceebral Hemorrhage 2 脑内出血Intraceebral Hemorrhage 2 脑内出血;rFVIIa in thrombocytopenic patients;TreatmentrFVIIa in thrombocytopenia;TreatmentrFVIIa in thrombocytopenia;TreatmentrFVIIa in thrombocytopenia;Treatment rFVIIa in hematopoietic stem cell transplant patients with bleeding;Treatment rFVIIa in hematopoietic stem cell transplant patients with bleeding;Treatment rFVIIa in hematopoietic stem cell transplant patients with bleeding;Treatment RCT: rFVIIa in hematopoietic stem cell transplant patients with bleeding;Treatment RCT: rFVIIa in hematopoietic stem cell transplant patients with bleeding;TreatmentCase report: rFVIIa in ITP patient with ICH;Treatment Case report: rFVIIa in platelet refractory AML patient with ICH;Treatment Case report: rFVIIa in platelet refractory AML patient with ICH;Summary;References;;Fatal Intra